Procaps Group SA (PROC)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
May 22, 16:00
2.88
+0.08
(+2.86%)
After-Hours: 20:00
Procaps Group Cash and Short Term Investments (Quarterly): 25.83M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 25.83M |
| June 30, 2023 | 19.97M |
| March 31, 2023 | 23.03M |
| December 31, 2022 | 43.00M |
| September 30, 2022 | 27.22M |
| Date | Value |
|---|---|
| June 30, 2022 | 37.55M |
| March 31, 2022 | 65.64M |
| December 31, 2021 | 72.11M |
| September 30, 2021 | 100.19M |
| December 31, 2020 | 4.229M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.229M
Minimum
Dec 2020
100.19M
Maximum
Sep 2021
41.88M
Average
32.38M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Alvotech | 64.81M |
| Moolec Science SA | 1.834M |
| Perspective Therapeutics Inc | 180.65M |
| Electromed Inc | 11.71M |
| Xtant Medical Holdings Inc | 4.547M |